Inhibrx Biosciences, Inc. valuation and forecast
Explore the models for Inhibrx Biosciences, Inc., adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: every model's value for Inhibrx Biosciences, Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.
Price vs value
Under review: data-quality checks not passed. We'll show the comparison once resolved.
Analyst recommendations
Monthly trend
- Oct 20264
- Sep 20264
- Aug 20264
Counts of recommendations published by analysts covering Inhibrx Biosciences, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.
Price history
Loading chart…
Third-party market data · may be delayed
INBX valuation questions
- How does Fundamentalytics value Inhibrx Biosciences, Inc.?
- We use the models that fit Inhibrx Biosciences, Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Inhibrx Biosciences, Inc.